Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Daiichi Sankyo
Dow
Fuji
McKesson
Accenture
Merck
McKinsey
Farmers Insurance

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204691

« Back to Dashboard

NDA 204691 describes ACETAZOLAMIDE, which is a drug marketed by Heritage Pharms Inc, Nostrum Labs Inc, Novast Labs Ltd, Zydus Pharms Usa Inc, Alra, Ascot, Heritage Pharma, Lannett, Strides Pharma, Sun Pharm Industries, Taro, Vangard, Watson Labs, Hospira, Mylan Asi, Par Sterile Products, West-ward Pharms Int, X Gen Pharms, and Emcure Pharms Ltd, and is included in twenty NDAs. It is available from eighteen suppliers. Additional details are available on the ACETAZOLAMIDE profile page.

The generic ingredient in ACETAZOLAMIDE is acetazolamide sodium. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.
Summary for 204691
Tradename:ACETAZOLAMIDE
Applicant:Nostrum Labs Inc
Ingredient:acetazolamide
Patents:0
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 204691
Ingredient-typeSulfonamides
Mechanism of ActionCarbonic Anhydrase Inhibitors
Medical Subject Heading (MeSH) Categories for 204691
Suppliers and Packaging for NDA: 204691
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACETAZOLAMIDE acetazolamide CAPSULE, EXTENDED RELEASE;ORAL 204691 ANDA Nostrum Laboratories, Inc. 29033-030 N 29033-030-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength500MG
Approval Date:Mar 29, 2016TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Baxter
UBS
US Army
Cerilliant
Express Scripts
Cipla
Chubb
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.